Patents by Inventor Timo Arto Sorsa

Timo Arto Sorsa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5866432
    Abstract: The present invention is related to a rapid and reliable method for making chair-side diagnoses of periodontal diseases and especially for predicting the risk of progressing of the periodontal diseases. The diagnosis and prognosis are performed using an immunological test kit by which increased levels of neutrophil gelatinase-related lipocalin (NGAL) derived from polymorphonuclear neutrophilic leucocytes PMNs) is measured.
    Type: Grant
    Filed: December 11, 1996
    Date of Patent: February 2, 1999
    Assignee: Oy Medix Biochemica AB
    Inventors: Timo Arto Sorsa, Sari Hannele Tikanoja, Leila Christina Lundqvist
  • Patent number: 5736341
    Abstract: Methods and test kits are described which provide a reliable, sensitive and selective assessment of periodontal disease activity, peri-implantitis or HIV(+)-infection/AIDS-disease related periodontal diseases. The preferred methods and test kits are constructed to be easy and rapid chair-side tests. The method is based on the preparation and use of monoclonal antibodies which recognize the active mammalian matrix metalloproteinase-S (MMP-8) and is capable of differentiating between said active matrix metalloproteinase-8 and its inactive proform.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 7, 1998
    Assignee: Oy Medix Biochemica AB
    Inventors: Timo Arto Sorsa, Sari Hannele Tikanoja, Leila Christina Lundqvist
  • Patent number: 5652227
    Abstract: Bis-phosphonates such as clodronate, etidronate, pamidronate and alendronate are found to inhibit the degradation of connective tissue matrix protein components in mammals, including humans, and therefore are useful in the therapeutic and prophylactic treatment of mammals against a variety of physiological and pathological connective tissue disorders or extracellular protein degradation disorders including wounds, burns, fractures, lesions, ulcers, cancer and metastasis progression in connective tissues, rheumatoid arthritis and other arthitides, periodontitis, peri-implantitis, cysts, root canal treatment, AIDS, ulceration of the cornea, gastric ulceration, aftae, trauma, acne, psoriasis, loosening of end-osseal hip-protheses.
    Type: Grant
    Filed: January 30, 1995
    Date of Patent: July 29, 1997
    Inventors: Olli Pekka Teronen, Timo Arto Sorsa, Tuula Anneli Salo